
Panpharma appoints Novartis senior head
pharmafile | July 22, 2013 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |Â Â Novartis, celesio AG, panpharmaÂ
Pharma trading group Celesio AG has announced that Alexander Triebnigg has taken over the management of the Brazilian pharma wholesaler Panpharma.
Triebnigg has gained many years of leadership experience in the Brazilian pharma market: From 2006 to 2010 as general manager of Novartis Pharma and as of 2011 as President of Novartis Group, leading all six business divisions in Brazil.
Prior to this he held the positions of general manager of Novartis Pharma Portugal, general manager of Fisher Scientific Germany & Central and Eastern Europe and various commercial leadership positions at Merck in Austria, Belgium and within the European region.
Nikolaus Vogler who in addition to his role as director of Operations took on the duties of the chairman of the management Board in May of last year, will concentrate on his responsibilities in operations as planned.
Related Content

Novartis receives SMC approval for early breast cancer treatment
Novartis has announced that its treatment for early breast cancer, Kisqali (ribociclib), has received approval …

Novartis candidate for Sjögren’s disease presents positive results
Novartis has reported positive results from two phase 3 clinical trials – NEPTUNUS-1 and NEPTUNUS-2 …

First malaria medicine for infants under 4.5kg receives approval
Coartem (artemether-lumefantrine) Baby, or Riamet, has been approved by Swissmedic as the first malaria medicine …






